Search Results for: F2RL1

84 interactions involving F2RL1 - F2R like trypsin receptor 1 found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
RGR retinal G protein coupled receptor
  • G alpha (i) signalling events
  • Opsins
  • Retinitis pigmentosa (RP)
RTN1 reticulon 1
RTN4 reticulon 4
  • Axonal growth inhibition (RHOA activation)
SCN1B sodium voltage-gated channel beta subunit 1
  • Interaction between L1 and Ankyrins
  • Phase 0 - rapid depolarisation
  • Sensory perception of sweet, bitter, and umami (glutamate) taste
  • Ranolazine
  • Phenytoin
  • Valproic acid
  • Oxcarbazepine
  • Cocaine
  • Zonisamide
  • Brivaracetam
  • Dichlorobenzyl alcohol
  • Fish oil
  • Febrile seizures, including: Febrile convulsions; Generalized epilepsy with febrile seizure plus (GEFS+); Dravet syndrome/ Severe myoclonic epilepsy in infancy (SMEI)
  • Brugada syndrome (BRS)
SDHD succinate dehydrogenase complex subunit D
  • Respiratory electron transport
  • Citric acid cycle (TCA cycle)
  • Maturation of TCA enzymes and regulation of TCA cycle
  • Hexachlorophene
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • Ubiquinone Q1
  • Carcinoid
SLC12A5 solute carrier family 12 member 5
  • Cation-coupled Chloride cotransporters
  • Potassium chloride
  • Bumetanide
SLC18B1 solute carrier family 18 member B1
SLC1A4 solute carrier family 1 member 4
  • Amino acid transport across the plasma membrane
  • Alanine
SLC31A2 solute carrier family 31 member 2
SLC32A1 solute carrier family 32 member 1
  • SLC-mediated transport of neurotransmitters
  • GABA synthesis, release, reuptake and degradation
SLC35A1 solute carrier family 35 member A1
  • Sialic acid metabolism
  • Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
  • Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
  • Transport of nucleotide sugars
  • Matriglycan biosynthesis on DAG1
  • Congenital disorders of glycosylation (CDG) type II
SLC39A13 solute carrier family 39 member 13
  • Ehlers-Danlos syndrome (EDS), including: EDS classical type (EDS1/2); EDS hypermobility type (EDS3); EDS vascular type (EDS4); EDS kyphoscoliosis type (EDS6); EDS arthrochalasia type (EDS7A/7B); EDS dermatospraxis type (EDS7C); EDS autosomal recessive cardiac valvular form (EDSCV); EDS musculocontractural type (EDSMC); EDS progeroid form (EDSP); Tenascin-X deficiency (TNXD); Brittle cornea syndrome (EDS6B); EDS-like spondylocheiro dysplasia (SCD-EDS)
SLC43A2 solute carrier family 43 member 2
  • Amino acid transport across the plasma membrane
SLC75A1 solute carrier family 75 member 1
ST14 ST14 transmembrane serine protease matriptase
  • Formation of the cornified envelope
  • Formation of the cornified envelope
  • Urokinase
  • Benzamidine
  • Camostat
  • Ichthyosis with hypotrichosis
SYNGR2 synaptogyrin 2
TMBIM1 transmembrane BAX inhibitor motif containing 1
  • Neutrophil degranulation
TMED1 transmembrane p24 trafficking protein 1
TMEM161A transmembrane protein 161A
TMEM62 transmembrane protein 62

Page 4 out of 5 pages